Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00877708 · ClinicalTrials.gov registry record
Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol
A clinical trial of E Coli Infections, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT00877708: Completed study of E Coli Infections, sponsored by University of Pittsburgh.
NCT00877708 is a study of E Coli Infections that has completed, run by University of Pittsburgh. The registered enrollment target is 150 participants, below the 1,160-participant average among 4 other E Coli Infections trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00877708, a study of E Coli Infections, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to review patients with E. coli infections at UPMC from September 1, 2008 to August 31, 2010 to determine if these infections have arisen in the community rather than in hospitals or nursing homes and determine their clinical outcomes. The specific aims of this study are to: 1. Review whether cephalosporin-resistant E. coli infections are hospital-acquired, healthcare-associated or community-associated. 2. Determine the clinical outcome of the patients according to the antibiotics given.
Primary Outcome
health status
Conditions Studied
Study Locations (1)
Pennsylvania
- UPMC - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2009-03 |
| Est. Completion | 2017-12 |
What the finished NCT00877708 record still lists
NCT00877708 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,160-participant average among 4 other E Coli Infections trials with a reported enrollment target (87% lower).
The record links to 1 condition, with E Coli Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00877708 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00877708 about?
NCT00877708 is a clinical study titled "Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol". The purpose of this study is to review patients with E. coli infections at UPMC from September 1, 2008 to August 31, 2010 to determine if these infections have arisen in the community rather than in hospitals or nursing homes and determine their clinical outcomes. The specific aims of this study ar...
What is the current status of trial NCT00877708?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2009-03. Estimated completion is 2017-12.
What conditions does trial NCT00877708 study?
This clinical trial studies the following conditions: E Coli Infections.
Who is sponsoring clinical trial NCT00877708?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00877708 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for E Coli Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant
RECRUITING · Phase 1
-
Community - Associated Extended-spectrum Beta-lactamases (ESBL)
COMPLETED
-
A Study Investigating the Safety, Recovery, and Pharmacodynamics of Multiple Oral Administrations of SNIPR001 in Healthy Subjects
COMPLETED · Phase 1
-
Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli (EXPECT-1)
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia